Thoratec

Global Ventricular Assist Device Market Size, Share & Trends Analysis Report (2020-2027) - ResearchAndMarkets.com

Retrieved on: 
Monday, March 16, 2020
Medical devices, Health, Medicine, Cardiology, Interventional cardiology, Medical specialties, Medical devices, Medical technology, Prosthetics, Ventricular assist device, LVAD, Thoratec

The "Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product (LVAD, RVAD, BiVAD, TAH), by Type of Flow (Pulsatile, Continuous), by Design, by Application, by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product (LVAD, RVAD, BiVAD, TAH), by Type of Flow (Pulsatile, Continuous), by Design, by Application, by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global ventricular assist device market size is expected to reach USD 4.1 billion by 2027, according to this report registering a CAGR of 11.7% over the forecast period.
  • Increase in global geriatric population, along with their susceptibility to cardiovascular diseases, is a major factor driving the market growth.
  • Further key findings from the report suggest:
    Left ventricular assist devices emerged as the largest product segment in 2019 with a share of 76.9% in the global ventricular assist device market.

Inari Medical Appoints Cynthia Lucchese and Catherine Szyman to the Company's Board of Directors

Retrieved on: 
Tuesday, January 28, 2020
Eli Lilly and Company, Guidant, Thoratec

IRVINE, Calif., Jan. 28, 2020 /PRNewswire/ --Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Cynthia Lucchese and Catherine Szyman to the company's Board of Directors.

Key Points: 
  • IRVINE, Calif., Jan. 28, 2020 /PRNewswire/ --Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Cynthia Lucchese and Catherine Szyman to the company's Board of Directors.
  • "We are pleased to welcome Cindy and Katie as new independent directors to our board.
  • Ms. Lucchese and Ms. Szyman have served as members of the Board of Directors since November 2019.Ms.
  • Ms. Lucchese has experience with medical device and life sciences companies, including Guidant, Thoratec and Eli Lilly.

Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality

Retrieved on: 
Monday, January 20, 2020
Occupations, Regulatory affairs, Thoratec, Human activities, Humans

Mr. Middlebrook brings to Nevro more than 30 years of senior leadership experience in regulatory affairs, clinical affairs and quality assurance in the medical device industry.

Key Points: 
  • Mr. Middlebrook brings to Nevro more than 30 years of senior leadership experience in regulatory affairs, clinical affairs and quality assurance in the medical device industry.
  • "We're pleased to have a leader of Don's caliber join Nevro to advance our clinical pipeline and oversee our global regulatory and quality initiatives," said D. Keith Grossman, Chairman, CEO and President of Nevro.
  • At Thoratec, Mr. Middlebrook was Vice President of Corporate Quality and Regulatory Affairs for 19 years, where he was responsible for gaining worldwide regulatory approvals, leading numerous groundbreaking clinical trials and overseeing the company's quality systems.
  • Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
    To learn more about Nevro, connect with us on LinkedIn , Twitter , Facebook and Instagram .

FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery

Retrieved on: 
Tuesday, January 7, 2020
Medicine, Medical specialties, Clinical medicine, Interventional cardiology, Cardiology, Medical devices, Prosthetics, Ventricular assist device, Thoracotomy, Thoratec, William F. Bernhard

ABBOTT PARK, Ill., Jan. 7, 2020 /PRNewswire/ -- Abbott (NYSE: ABT)today announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery.

Key Points: 
  • ABBOTT PARK, Ill., Jan. 7, 2020 /PRNewswire/ -- Abbott (NYSE: ABT)today announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery.
  • The new, less invasive approach is designed to provide surgeons a choice in surgical method for patients receiving the HeartMate 3 Left Ventricular Assist Device (LVAD), the industry's leading heart pump.
  • With approval for an alternative surgical technique, Abbott's HeartMate 3 heart pump can now be implanted via lateral thoracotomy a surgical approach where an incision is made between a patient's ribs to access the heart.
  • Physicians believe that for many patients this technique has advantages over open heart surgery because it can result in less bleeding and a shorter recovery time for patients.

The global ventricular assist devices market at a CAGR of almost 12% during the forecast period

Retrieved on: 
Monday, December 16, 2019
Medical specialties, Medicine, Cardiovascular system, Cardiology, Interventional cardiology, Medical devices, Prosthetics, Heart diseases, Ventricular assist device, Heart failure, Thoratec, Arrhythmogenic cardiomyopathy

Global Ventricular Assist Devices Market: About this market

Key Points: 
  • Global Ventricular Assist Devices Market: About this market
    This ventricular assist devices market analysis considers sales from left and right ventricular assist devices and bi-ventricular assist devices products.
  • However, high costs associated with ventricular assist devices, complications related to implantation of ventricular assist devices, and frequent product recalls may hamper the growth of the ventricular assist devices industry over the forecast period.
  • Global Ventricular Assist Devices Market: Overview
    Patients who suffer from chronic cardiovascular diseases have a high risk of developing heart failure.
  • Thus, the increasing prevalence of heart failure will lead to the expansion of the global ventricular assist devices market at a CAGR of almost 12% during the forecast period.

Monique DeWolf joins Children's Minnesota Foundation Board of Directors

Retrieved on: 
Wednesday, November 27, 2019
Geography of Minnesota, States of the United States, Minnesota, Thoratec, St. Jude Medical, Minneapolis

MINNEAPOLIS, Nov. 27, 2019 /PRNewswire/ --Children's Minnesota Foundation announced today the appointment of Monique DeWolf to its board of directors.

Key Points: 
  • MINNEAPOLIS, Nov. 27, 2019 /PRNewswire/ --Children's Minnesota Foundation announced today the appointment of Monique DeWolf to its board of directors.
  • "We are thrilled to welcome Monique to our foundation board of directors," said Jennifer Soderholm, chief development officer and president of the Children's Minnesota Foundation.
  • The foundation board of directors is comprised of community leaders and Children's staff members who are selected based on their experience and expertise.
  • DeWolf brings extensive health care experience to the board after serving in several high-level positions as a consultant for CentriMag at Abbott Medical, St. Jude Medical and Thoratec Corporation.

Global Ventricular Assist Devices and Total Artificial Heart Market to 2023: Opportunities in Application of Advanced Biomaterials in Artificial Organs & Organ-on-Chips Technology

Retrieved on: 
Thursday, August 1, 2019
Cardiology, Medicine, Medical specialties, Medical devices, Prosthetics, Medical technology, Interventional cardiology, Artificial heart, Ventricular assist device, Thoratec, Gus Rosenberg

The global ventricular assist devices and artificial heart systems market was estimated at $2.20 billion in 2018 and is estimated to reach $2.70 billion by 2023.

Key Points: 
  • The global ventricular assist devices and artificial heart systems market was estimated at $2.20 billion in 2018 and is estimated to reach $2.70 billion by 2023.
  • The increasing mortality rate triggered the use of mechanical circulatory support devices such as ventricular assist devices and artificial heart systems in the market.
  • According to Nidhi Srivastava, North America is currently the leading contributor in the global ventricular assist devices and artificial heart systems market.
  • Based on product type, ventricular assist devices possessed the highest market share in the global ventricular assist devices and artificial heart systems market in 2018.

Global $2.7 Bn Ventricular Assist Devices and Total Artificial Heart Market 2019-2023: Focus on Products, Distribution Channels, Regional, Data - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 1, 2019
Health, Medical devices, Cardiology, Cardiology, Medicine, Medical specialties, Medical devices, Medical technology, Prosthetics, Interventional cardiology, Artificial heart, Ventricular assist device, Cardiac electrophysiology, Thoratec

What are the major market drivers, challenges, and opportunities in the global ventricular assist devices and artificial heart systems?

Key Points: 
  • What are the major market drivers, challenges, and opportunities in the global ventricular assist devices and artificial heart systems?
  • What are the leading companies dominating the global ventricular assist devices and artificial heart systems market?
  • What are investors' perceptions about the global ventricular assist devices and artificial heart systems market?
  • What was the market value of the leading segments and sub-segments of the global ventricular assist devices and artificial heart systems market?

Global Ventricular Assist Device (VAD) Market 2019-2025: Analysis by Product, Type of Flow, Application, and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 20, 2019
Health, Medical devices, Cardiology, Medicine, Medical specialties, Cardiology, Interventional cardiology, Medical devices, Cardiovascular system, Prosthetics, Ventricular assist device, LVAD, Vad, Heart failure, Thoratec

The "Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global ventricular assist device market size is expected to reach USD 2,464.9 million by 2025, at a CAGR 11.4% over a forecast period.
  • Ventricular assist device (VAD) market is majorly driven by rising prevalence of heart failures, shortage of organ donors, and recent technological advancements improving the quality of lives of patients with weakened heart.
  • Increasing number of research activities and new product launches are some of the major factors contributing to the market growth.

Global $2.98 Bn Cardiac Assist Devices Market Forecast up to 2025 - Key Players are Abbott Laboratories, Berlin Heart, Maquet, SynCardia Systems and ReliantHeart - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 18, 2019
Health, Cardiology, Medical devices, Medicine, Cardiology, Interventional cardiology, Medical devices, Prosthetics, Medical technology, Ventricular assist device, Thoratec

The ventricular assist devices market is further segmented into left ventricular assist devices, right ventricular assist devices, and biventricular assist devices.

Key Points: 
  • The ventricular assist devices market is further segmented into left ventricular assist devices, right ventricular assist devices, and biventricular assist devices.
  • Among these, left ventricular assist devices occupied a major share and is expected to grow at high CAGR during the forecast period.
  • Cardiac Assist Devices Market Research Competitive Analysis - The global cardiac assist devices market has massive growth opportunities in both developed and developing regions.
  • The report provides complete details about the current and forecast market size of every type of cardiac assist devices and market values by region.